A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles.

A sensitive and rapid immunoassay for the detection of tumor necrosis factor (TNF) has been developed. Magnetic monodisperse polymer particles (M-280 Dynabeads) used as solid phase material, were coated with a neutralizing mouse monoclonal antibody to TNF. The coated Dynabeads were shown to have a more rapid binding capacity for recombinant (r) TNF as compared to standard immunowells coated with antibodies to TNF. The amount of TNF bound to the Dynabeads was quantified using either a polyclonal antibody to TNF or a mouse monoclonal antibody to TNF. The antibodies used for detection were either labelled with 125I or peroxidase. The linear assay range for the TNF standard curve was form 62 to 4000 pg/ml, and the assay time was less than 60 min. The sensitivity could be increased 5-8-fold by increasing the sample volume from 0.1 to 2 ml.

[1]  P. Brandtzaeg,et al.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response , 1989, The Journal of experimental medicine.

[2]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[3]  C. Janeway,et al.  Elevated temperature regulates tumor necrosis factor‐mediated immune killing , 1989, European journal of immunology.

[4]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[5]  Andrew J. S. Jones,et al.  ELISA for quantitation of tumor necrosis factor-α in serum , 1987 .

[6]  T. Espevik,et al.  Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. , 1988, Cancer research.

[7]  B. Aggarwal,et al.  Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes. , 1987, Hybridoma.

[8]  N. de Tribolet,et al.  Effects of recombinant human tumor necrosis factor‐α on the surface phenotype and the growth of human malignant glioma cell lines , 1988 .

[9]  K. Bendtzen,et al.  Detection of Tumour Necrosis Factor from Lipopolysaccharide‐Stimulated Human Mononuclear Cells by Enzyme‐Linked Immunosorbent Assay and Cytotoxicity Bioassay , 1988, Scandinavian journal of immunology.

[10]  J. Tavernier,et al.  EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.

[11]  T. Espevik,et al.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.

[12]  B. Aggarwal,et al.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity , 1984, Nature.

[13]  A. Cerami,et al.  Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines , 1988, The Journal of experimental medicine.

[14]  Y. Ohkaru,et al.  Simple enzyme immunoassay methods for recombinant human tumor necrosis factor alpha and its antibodies using a bacterial cell wall carrier. , 1988, Journal of immunological methods.

[15]  K. Nustad,et al.  Excess antibody immunoassays for rat glandular kallikreins. Measurement of kallikrein from different organs in the presence of cross-reacting antigens. , 1983, Journal of immunological methods.

[16]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Bosma,et al.  The Clonal Nature of Antibody Formation , 1972 .

[18]  P. Scuderi,et al.  RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS , 1986, The Lancet.

[19]  K. Nustad,et al.  Hydrophilic monodisperse particles as solid-phase material in immunoassays: comparison of shell-and-core particles with compact particles. , 1984, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[20]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[21]  M. E. Carver,et al.  Serum-free in vitro bioassay for the detection of tumor necrosis factor. , 1986, Journal of immunological methods.

[22]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[23]  G. Rice,et al.  The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. , 1988, Journal of immunology.

[24]  C. Maury,et al.  Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection , 1987, The Journal of experimental medicine.